Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.383
H.R.383: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
About This Bill
- Introduced Jan. 17, 2023
- Latest Major Action Jan. 27, 2023
Bill Sponsor
Bill Cosponsors
26 (All Republicans)
Bill Version
- Introduced in House - Jan. 17, 2023
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Jan. 27, 2023 |
Referred to the Subcommittee on Health.
|
Jan. 17, 2023 |
Referred to the House Committee on Energy and Commerce.
|
Jan. 17, 2023 |
Introduced in the House by Diana Harshbarger (R-Tenn.) |